<?xml version="1.0" ?>
<document id="d9b9b75ee4d554ad43e8a8531af0b6763a1d6652">
  <chunk id="d9b9b75ee4d554ad43e8a8531af0b6763a1d6652.c0" text="CEACAM1 promotes CD8 + T cell responses and improves control of a chronic viral infection">
    <entity charOffset="74-89" id="d9b9b75ee4d554ad43e8a8531af0b6763a1d6652.c0.e0" ontology_id="DOID_934" text="viral infection" type="disease"/>
  </chunk>
  <chunk id="d9b9b75ee4d554ad43e8a8531af0b6763a1d6652.c1" text="Dysfunction of CD8 + T cells can lead to the development of chronic viral infection. Identifying mechanisms responsible for such T cell dysfunction is therefore of great importance to understand how to prevent persistent viral infection. Here we show using lymphocytic choriomeningitis virus (LCMV) infection that carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) is fundamental for recruiting lymphocyte-specific protein kinase (Lck) into the T cell receptor complex to form an efficient immunological synapse. CEACAM1 is essential for activation of CD8 + T cells, and the absence of CEACAM1 on virus-specific CD8 + T cells limits the antiviral CD8 + T cell response. Treatment with anti-CEACAM1 antibody stabilizes Lck in the immunological synapse, prevents CD8 + T cell exhaustion, and improves control of virus infection in vivo. Treatment of human virus-specific CD8 + T cells with anti-CEACAM1 antibody similarly enhances their proliferation. We conclude that CEACAM1 is an important regulator of virus-specific CD8 + T cell functions in mice and humans and represents a promising therapeutic target for modulating CD8 + T cells.">
    <entity charOffset="257-285" id="d9b9b75ee4d554ad43e8a8531af0b6763a1d6652.c1.e0" ontology_id="DOID_12155" text="lymphocytic choriomeningitis" type="disease"/>
    <entity charOffset="361-369" id="d9b9b75ee4d554ad43e8a8531af0b6763a1d6652.c1.e1" ontology_id="CHEBI_25367" text="molecule" type="chemical"/>
    <entity charOffset="432-439" id="d9b9b75ee4d554ad43e8a8531af0b6763a1d6652.c1.e2" ontology_id="CHEBI_16541" text="protein" type="chemical"/>
    <entity charOffset="654-663" id="d9b9b75ee4d554ad43e8a8531af0b6763a1d6652.c1.e3" ontology_id="CHEBI_22587" text="antiviral" type="chemical"/>
    <entity charOffset="827-842" id="d9b9b75ee4d554ad43e8a8531af0b6763a1d6652.c1.e4" ontology_id="DOID_934" text="virus infection" type="disease"/>
    <pair e1="d9b9b75ee4d554ad43e8a8531af0b6763a1d6652.c1.e0" e2="d9b9b75ee4d554ad43e8a8531af0b6763a1d6652.c1.e1" id="d9b9b75ee4d554ad43e8a8531af0b6763a1d6652.c1.p0" relation="true"/>
    <pair e1="d9b9b75ee4d554ad43e8a8531af0b6763a1d6652.c1.e0" e2="d9b9b75ee4d554ad43e8a8531af0b6763a1d6652.c1.e2" id="d9b9b75ee4d554ad43e8a8531af0b6763a1d6652.c1.p1" relation="true"/>
    <pair e1="d9b9b75ee4d554ad43e8a8531af0b6763a1d6652.c1.e0" e2="d9b9b75ee4d554ad43e8a8531af0b6763a1d6652.c1.e3" id="d9b9b75ee4d554ad43e8a8531af0b6763a1d6652.c1.p2" relation="true"/>
    <pair e1="d9b9b75ee4d554ad43e8a8531af0b6763a1d6652.c1.e1" e2="d9b9b75ee4d554ad43e8a8531af0b6763a1d6652.c1.e4" id="d9b9b75ee4d554ad43e8a8531af0b6763a1d6652.c1.p3" relation="true"/>
    <pair e1="d9b9b75ee4d554ad43e8a8531af0b6763a1d6652.c1.e2" e2="d9b9b75ee4d554ad43e8a8531af0b6763a1d6652.c1.e4" id="d9b9b75ee4d554ad43e8a8531af0b6763a1d6652.c1.p4" relation="true"/>
    <pair e1="d9b9b75ee4d554ad43e8a8531af0b6763a1d6652.c1.e3" e2="d9b9b75ee4d554ad43e8a8531af0b6763a1d6652.c1.e4" id="d9b9b75ee4d554ad43e8a8531af0b6763a1d6652.c1.p5" relation="true"/>
  </chunk>
</document>
